Endogenous Interleukin-1β Is Implicated in Intraplaque Hemorrhage in Apolipoprotein E Gene Null Mice

Circ J. 2018 Mar 23;82(4):1130-1138. doi: 10.1253/circj.CJ-17-1023. Epub 2018 Feb 22.

Abstract

Background: Intraplaque hemorrhage (IPH) has been implicated in plaque instability and rupture in atherosclerotic lesions, although the mechanisms by which IPH progresses remain largely unknown. In this study, apolipoprotein E-deficient mice with carotid artery ligation and cuff placement around the artery were used, and pro-inflammatory cytokines that are implicated in IPH were analyzed.Methods and Results:The expression of interleukin-1β (IL-1β) increased significantly following cuff placement compared with mice with carotid artery ligation alone. IPH occurred in the cuff-placed carotid artery following treatment with the negative control (NC) small interfering RNA (siRNA). However, the occurrence was significantly reduced in the cuff-placed carotid artery following treatment with an IL-1β siRNA. Neovessel formation was significantly reduced in the carotid artery treated with the NC siRNA compared with that treated with IL-1β siRNA. IL-1β significantly inhibited the tube formation and wound healing capacities of vascular endothelial cells in vitro. Furthermore, immunostaining of matrix metalloproteinase-9 (MMP-9) significantly increased in the carotid artery treated with the NC siRNA compared with that treated with IL-1β siRNA.

Conclusions: These results suggest that endogenous IL-1β is implicated in the progression of IPH via the inhibition of physiological angiogenesis in the atherosclerotic plaque, leading to the formation of leaky neovessels. Furthermore, the stimulation of MMP-9 expression may also contribute to the formation of leaky neovessels.

Keywords: Angiogenesis; Interleukin-1β; Intraplaque hemorrhage; Matrix metalloproteinase-9.

MeSH terms

  • Angiogenesis Inhibitors / pharmacology
  • Animals
  • Apolipoproteins E / deficiency
  • Apolipoproteins E / genetics*
  • Carotid Arteries / surgery
  • Endothelial Cells / drug effects
  • Endothelial Cells / pathology
  • Hemorrhage*
  • Interleukin-1beta / analysis
  • Interleukin-1beta / pharmacology*
  • Ligation
  • Matrix Metalloproteinase 9 / metabolism
  • Mice
  • Mice, Knockout
  • Plaque, Atherosclerotic / pathology*
  • RNA, Small Interfering / pharmacology

Substances

  • Angiogenesis Inhibitors
  • Apolipoproteins E
  • Interleukin-1beta
  • RNA, Small Interfering
  • Matrix Metalloproteinase 9
  • Mmp9 protein, mouse